Akh Wien

Vienna 1090

0 studies enrolling now · 15 studies all time

What they study most

Acute Myeloid Leukemia, BRAF V600E-mutant Metastatic Colorectal Cancer, Crohn's Disease, Diabetes Mellitus, Type 2, HIV Infections, Head and Neck Cancer, Heart Failure, Neuralgia, Postherpetic, Non-small Cell Lung Cancer, Peripheral Arterial Disease, Pulmonary Arterial Hypertension, Squamous Cell Cancer

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• HER2 and LA/mUC: A Multi-country Chart Review Cohort Study — Completed
• The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension — Completed
• The ARIES HeartMate 3 Pump IDE Study — Completed
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• Zalutumumab in Non-curable Patients With SCCHN — Completed
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads — Stopped early
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine — Completed